Takeda Pharmaceuticals International Ag - Net Worth and Insider Trading
Takeda Pharmaceuticals International Ag Net Worth
The estimated net worth of Takeda Pharmaceuticals International Ag is at least $200 Million dollars as of 2024-09-19. Takeda Pharmaceuticals International Ag is the 10% Owner of Myovant Sciences Ltd and owns about 7,420,625 shares of Myovant Sciences Ltd (MYOV) stock worth over $200 Million. Details can be seen in Takeda Pharmaceuticals International Ag's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Takeda Pharmaceuticals International Ag has not made any transactions after 2018-03-19 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Takeda Pharmaceuticals International Ag
Takeda Pharmaceuticals International Ag Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Takeda Pharmaceuticals International Ag owns 3 companies in total, including Quince Therapeutics Inc (QNCX) , Myovant Sciences Ltd (MYOV) , and Molecular Templates Inc (MTEM) .
Insider Ownership Summary of Takeda Pharmaceuticals International Ag
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| QNCX | Quince Therapeutics Inc | 2019-05-08 | 10 percent owner |
| MYOV | Myovant Sciences Ltd | 2018-03-19 | 10 percent owner |
| MTEM | Molecular Templates Inc | 2017-08-01 | 10 percent owner |
Takeda Pharmaceuticals International Ag Latest Holdings Summary
Takeda Pharmaceuticals International Ag currently owns a total of 1 stock. Takeda Pharmaceuticals International Ag owns 7,420,625 shares of Myovant Sciences Ltd (MYOV) as of March 19, 2018, with a value of $200 Million.
Latest Holdings of Takeda Pharmaceuticals International Ag
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| MYOV | Myovant Sciences Ltd | 2018-03-19 | 7,420,625 | 26.98 | 200,208,463 |
Holding Weightings of Takeda Pharmaceuticals International Ag
Takeda Pharmaceuticals International Ag Form 4 Trading Tracker
According to the SEC Form 4 filings, Takeda Pharmaceuticals International Ag has made a total of 0 transactions in Myovant Sciences Ltd (MYOV) over the past 5 years. The most-recent trade in Myovant Sciences Ltd is the sale of 7,420,625 shares on March 19, 2018, which brought Takeda Pharmaceuticals International Ag around $139 Million.
Insider Trading History of Takeda Pharmaceuticals International Ag
- 1
Takeda Pharmaceuticals International Ag Trading Performance
GuruFocus tracks the stock performance after each of Takeda Pharmaceuticals International Ag's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Takeda Pharmaceuticals International Ag is 30.07%. GuruFocus also compares Takeda Pharmaceuticals International Ag's trading performance to market benchmark return within the same time period. The performance of stocks bought by Takeda Pharmaceuticals International Ag within 3 months outperforms 1 times out of 1 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Takeda Pharmaceuticals International Ag's insider trading performs compared to the benchmark.
Performance of Takeda Pharmaceuticals International Ag
Average Return
Outperforming Transactions
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | 13.53 | | | | | |
| Relative Return to S&P 500(%) | 14.26 | | | | | |
Takeda Pharmaceuticals International Ag Ownership Network
Takeda Pharmaceuticals International Ag Owned Company Details
What does Quince Therapeutics Inc do?
Who are the key executives at Quince Therapeutics Inc?
Takeda Pharmaceuticals International Ag is the 10 percent owner of Quince Therapeutics Inc. Other key executives at Quince Therapeutics Inc include director & Chief Executive Officer Dirk Thye , Chief Business Officer Brendan Hannah , and President Charles S. Ryan .
Quince Therapeutics Inc (QNCX) Insider Trades Summary
Over the past 18 months, Takeda Pharmaceuticals International Ag made no insider transaction in Quince Therapeutics Inc (QNCX). Other recent insider transactions involving Quince Therapeutics Inc (QNCX) include a net purchase of 500,436 shares made by David Lamond , a net purchase of 322,500 shares made by Dirk Thye , and a net purchase of 110,686 shares made by Brendan Hannah .
In summary, during the past 3 months, insiders sold 0 shares of Quince Therapeutics Inc (QNCX) in total and bought 241,811 shares, with a net purchase of 241,811 shares. During the past 18 months, 0 shares of Quince Therapeutics Inc (QNCX) were sold and 990,009 shares were bought by its insiders, resulting in a net purchase of 990,009 shares.
Quince Therapeutics Inc (QNCX)'s detailed insider trading history can be found in Insider Trading Tracker table.
Quince Therapeutics Inc Insider Transactions
Takeda Pharmaceuticals International Ag Mailing Address
Above is the net worth, insider trading, and ownership report for Takeda Pharmaceuticals International Ag. You might contact Takeda Pharmaceuticals International Ag via mailing address: Thurgauerstrasse 130, Glattpark-opfikon, Zurich V8 8152.
Discussions on Takeda Pharmaceuticals International Ag
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
